Partners

Steve Cohen

Steve

Team

Partners

When I’m out of office

The office has a way of following me around…

What’s your motto?

Innovate or die

I’ve always liked investing. You think about the future, and then you make a bet on it and find out if you’re right or wrong.

I like smart people, I like creative people, I like people who are willing to take risks. It’s satisfying to back someone with a good idea and watch them see it through.

I value expertise—specialists not generalists. With Point72 Ventures, I sought out experts to lead specific, focused investing areas—I believe you need to do the work to identify the areas you want to focus on and then find the best opportunities within those themes.

I’m always trying to learn new things, satisfy my curiosity, and meet interesting people who are changing the world. I host dinners at my house where we pick a topic and bring in experts who are really revolutionizing their industry. We’ve talked about food science and how the world’s food supply is going to change. We did another on applying sports analytics to other problems.

AI is going to transform a lot of industries, make companies more dynamic, workers more productive. I want to invest in opportunities at the forefront of that innovation because five or ten years from now it’s going to be required to compete.

I’m an optimist—even when things look shaky, you can still see how much innovation is happening and how much it’s going to change our lives. I always tell my team that nature abhors a vacuum and that when things seem bad, smart entrepreneurs will come along with the next big idea to move our society forward. I’m a believer in technology and a believer in change. It will likely do a lot to improve everyone’s life.  That’s why I do it.

Prior experience:

  • Point72 Ventures I founded Point72 Ventures in 2016. The idea was to take some of what we did well on the hedge fund side of Point72—fundamental research, deep understanding of businesses, a perspective on how the world's changing—and apply it to venture investing. We’ve built teams in fintech, AI/ML, enterprise, and healthcare. The investors know the areas that they're investing in—they have deep, deep expertise.
  • Point72 Asset Management I founded Point72’s predecessor firm in 1992. What started as a handful of people investing $20 million is now 1,600+ people, and we manage more than $18 billion. I’m proud of the business and I like the work. I still manage a book today, though I’m also CEO and President. Over the past 30 years I’ve learned that the world keeps changing—you’ve got to keep adapting, you’ve got to keep up with what's going on, or you're going be out of business. That’s the approach I’ve always taken with the Firm. So far, it seems to be working.
  • The New York Mets I went to my first Mets game with my dad at the old Polo Grounds. After a long period of minority ownership, I bought the Mets in 2020, which was a dream come true. I see my role as a civic responsibility—holding the team in trust for the community and the fans. Ownership isn’t that different from my day job: bring in great, expert leadership, ask probing questions, and hold them accountable.
  • Cohen Veterans Network and Cohen Veterans Bioscience I set up a non-profit called the Cohen Veterans Network (CVN) in 2015 and underwrote Cohen Veterans Bioscience (CVB) to improve the mental healthcare, treatment, and quality of life for recently returned veterans and their families. My son, Robert, served in the United States Marine Corps, and while he came home fine, many of the people he served with came home suffering the invisible wounds of war. Half of all Iraq and Afghanistan veterans say they know a fellow veteran who attempted or died by suicide.  We launched CVN with one clinic in 2016—and based on its success have grown the network to 17 clinics on the way to 25. Our clinics are open to family members as well as the veterans, and I’m proud to say we’ve treated 21,000 patients to date and provided over 200,000 episodes of care. Through CVB, we’ve been advancing research to identify a biomarker to definitively diagnose brain disorders like PTSD and TBI and we’re working on the science we hope will lead to a therapeutic to treat PTSD.
  • The Steven & Alexandra Cohen Foundation My wife, Alexandra, and I founded the Steven & Alexandra Cohen Foundation in 2001 as a way to support things we care a lot about: children’s health, access to and quality of education, veterans’ services, Lyme Disease and related tickborne diseases, and the arts.

The Team

next, meet...

Dan Gwak